NHMRC has recently approved Clinical Practice Guidelines on Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child that was developed by the Australian Research Centre for the Health of Women and Babies (ARCH).
MNCLHD
Monday, January 31, 2011
NHMRC new guideline
NHMRC has recently approved Clinical Practice Guidelines on Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child that was developed by the Australian Research Centre for the Health of Women and Babies (ARCH).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment